TGFB1 and diabetes mellitus: Conversely, treatment with Vinpocetine in the Diabetes and Vinpocetine group significantly attenuated TGF-β1 immunoexpression compared to both the Diabetes and saline treatment group and the Normal Control group (p < 0.001) (Table 2).